Sandoz And Bio-Thera Get EU Nod For Bevacizumab
As Five Generics, Including Three More Imnovid Rivals, Are Endorsed By CHMP At May Meeting
At its May meeting, the EMA’s CHMP has issued positive opinions for Sandoz and Bio-Thera’s Avzivi partnered biosimilar rival to Avastin, as well as five generics that included a trio of pomalidomide products.
